Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway

被引:42
|
作者
Becker, K
Schneider, P
Hofmann, K
Mattmann, C
Tschopp, J
机构
[1] UNIV LAUSANNE,DEPT BIOCHEM,CH-1066 EPALINGES,SWITZERLAND
[2] SWISS INST EXPT CANC RES,BIL RES CTR,CH-1066 EPALINGES,SWITZERLAND
关键词
apoptosis; Fas(Apo-1/CD95); yeast two-hybrid; ubiquitin;
D O I
10.1016/S0014-5793(97)00758-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fas(Apo-1/CD95), a receptor belonging to the tumor necrosis factor receptor family, induces apoptosis when triggered by Fas ligand, Upon its activation, the cytoplasmic domain of Fas binds several proteins which transmit the death signal. We used the yeast two-hybrid screen to isolate Fas-associated proteins, Here we report that the ubiquitin-conjugating enzyme UBC9 binds to Fas at the interface between the death domain and the membrane-proximal region of Fas, This interaction is also seen in vivo. UBC9 transiently expressed in HeLa cells bound to the co-expressed cytoplasmic segment of Fas. FAF1, a Fas-associated protein that potentiates apoptosis (Chu et al. (1996) Proc. Natl. Acad. Sci. USA 92, 11894-11898), was found to contain sequences similar to ubiquitin, These results suggest that proteins related to the ubiquitination pathway may modulate the Fas signaling pathway. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 50 条
  • [1] CD95 (APO-1/Fas)-associating signalling proteins
    Peter, ME
    Kischkel, FC
    Hellbardt, S
    Chinnaiyan, AM
    Krammer, PH
    Dixit, VM
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 161 - 170
  • [2] Characterization of Fas (Apo-1, CD95)-Fas ligand interaction
    Schneider, P
    Bodmer, JL
    Holler, N
    Mattmann, C
    Scuderi, P
    Terskikh, A
    Peitsch, MC
    Tschopp, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18827 - 18833
  • [3] The CD95(APO-1/Fas) DISC and beyond
    M E Peter
    P H Krammer
    Cell Death & Differentiation, 2003, 10 : 26 - 35
  • [4] CD95(apo-1/fas) signalling and diseases
    Krammer, PH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R1 - R1
  • [5] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (01): : 26 - 35
  • [6] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [7] Fas (CD95, Apo-1) Ligand Gene Transfer
    Salah-Eddine Lamhamedi-Cherradi
    Youhai Chen
    Journal of Clinical Immunology, 2001, 21 : 24 - 29
  • [8] FasL-Fas/APO-1(CD95)系统
    孙长凯
    鞠躬
    生理科学进展, 1997, (02) : 42 - 44
  • [9] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06): : 1675 - 1687
  • [10] Fas/APO-1 (CD95) expression in myelodysplastic syndromes
    Lepelley, P
    Grardel, N
    Erny, O
    Iaru, T
    Obein, V
    Cosson, A
    Fenaux, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) : 307 - 312